Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Santhera Pharmaceuticals Holding AG. We currently have 0 research reports from 0 professional analysts.
Date | Source | Announcement |
---|---|---|
21Aug18 06:00 | GNW | Santhera to Report First Half-Year Financial Figures and Provide Corporate Update on September 4, 2018 |
05Jul18 06:00 | GNW | Santhera to Present Novel Data Highlighting the Clinical Relevance of Peak Expiratory Flow as Predictor of Disease Progression in Duchenne Muscular Dystrophy |
22Jun18 06:00 | GNW | UK's MHRA renews Early Access to Medicines Scheme Scientific Opinion for Santhera's Raxone® (idebenone) in Duchenne Muscular Dystrophy |
12Jun18 06:00 | GNW | Santhera Submits NDA in South Korea for Raxone® for the Treatment of LHON |
12Apr18 12:30 | GNW | Santhera's Shareholders Approve all Board Proposals at Today's Annual General Meeting |
05Apr18 06:00 | GNW | Santhera Announces Successful Completion of First Clinical Trial with Omigapil in Patients with Congenital Muscular Dystrophy |
20Mar18 06:00 | GNW | Santhera Reports Solid Top-line Growth in 2017 and Reiterates its Strategy to Obtain Approval for Idebenone in Duchenne Muscular Dystrophy |
Share: